Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

+6.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kip518 who wrote (632)	11/13/1997 5:14:00 PM
From: LLAH	Read Replies (1) of 1605

VEGF is only one of many genes which activate naturally occuring growth factors in the body which can initiate healing, angiogenesis, the growing of new arteries etc. Cutting edge, high stakes... This type of gene therapy is capable of replacing the current treatments for congestive heart failure, angina (chronic chest pain) and heart disease as well as peripheral disease.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next